Blog

CancerBot Founder Adam Blum Featured on Practical AI in Healthcare Podcast

Adam Blum

Mar 16, 2026

Golcadomide (GOLCA) oral CELMoD therapy targeting cereblon pathway in relapsed follicular lymphoma clinical trial

CancerBot founder Adam Blum has been featured on Practical AI in Healthcare, one of the leading podcasts exploring how artificial intelligence is creating real, measurable impact across the healthcare industry.

The episode — hosted by senior leaders including former VPs of life science technology groups and clinical informatics professionals from top-tier organisations — focuses on how AI can move beyond hype to deliver genuine value for patients and clinicians alike. Adam's appearance fits squarely within that mission.

In the 51-minute conversation, Adam shares the personal journey that led to CancerBot's creation. After being diagnosed with follicular lymphoma, he assumed he could easily find the latest treatment options, only to be met with a confusing, fragmented search process and databases designed for medical professionals rather than patients. That frustration became the foundation for something better.

The episode goes deep into the technical architecture behind CancerBot's approach to precision matching — in particular the Prompt Workbench, where biomedical experts refine extraction prompts to above 90% accuracy, and the use of conjunctive normal form to make complex eligibility logic tractable. Adam also explains why "best trial" means something different for every patient, and why most existing matchers fall short by relying on a handful of surface-level criteria rather than assessing full eligibility.

It's a candid and technically rich conversation that will resonate with anyone working at the intersection of AI and clinical research — and with patients who want to understand what genuinely rigorous trial matching looks like.

Listen to the episode on Spotify or search for Practical AI in Healthcare, Season 1, Episode 28 on your preferred podcast platform.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

Start your search for clinical trials now

New treatment options could be just a click away. Start a chat with CancerBot today and get matched with clinical trials tailored to you—quickly, easily, and at no cost.

Start your search for clinical trials now

New treatment options could be just a click away. Start a chat with CancerBot today and get matched with clinical trials tailored to you—quickly, easily, and at no cost.